The Week in Swiss Startups (19-23.6.2023) - Week #25
The third week of June ‘23 features 7 startups and 3 exits. Do you want to work in Swiss VCs? Apply now!
Hey there!
last week, Swiss startups raised CHF 30.9M over seven financing rounds. Worth mentioning the traction within cleantech startups, Lunaphore’s exit to US-based Bio-Techne Corporation, and Gain Therapeutics IPO at Nasdaq.
Jobs: Looking for a career in VCs? Apply now for two openings at Lightbird and Redalpine (links below).
Worth reading: Inside the Minds of European VCs // Speedinvest surveyed 437 investors across Europe to provide both founders and investors with a deeper understanding of how European VCs approach startup investments.
Have a great week,
Gian
AI/ML - B2B SaaS
Enterprise Bot: Undisclosed - Non-dilutive growth credit
Cleantech
bNovate: CHF 12M - Series C
TreaTech: CHF 9M - Series A
Neology Hydrogen: CHF 100k - Convertible Loan
Engineering
Distran: CHF 8.3M - Series B
Fintech
Elephants: CHF 500k - Pre-seed
Materials
Noriware: CHF 1M - Pre-seed
—
Exit
Gain Therapeutics listed at Nasdaq (IPO)
Bio-Techne Corporation acquires Lunaphore
mesoneer acquires contactify
—
Swisspreneur Podcast
Listen to Frank Floessel, serial entrepreneur, investor, and coach: Prioritizing Company Values - EP #326
—
Jobs in Swiss VCs
Apply as Associate at Lightbird (Zurich)
Join Redalpine as Visiting Analyst HealthTech
News